hydantoins has been researched along with Sclerosis, Systemic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellino, L; Black, CM; Branch, RA; Csuka, ME; May, DG; Olsen, NJ; Porter, JA; Tanner, SB; Wilkinson, GR | 1 |
Maas, D | 1 |
Ferraz, EC; Levy, JA; Wittig, EO | 1 |
1 review(s) available for hydantoins and Sclerosis, Systemic
Article | Year |
---|---|
[Antinuclear factors. Demonstration and clinico-diagnostic significance].
Topics: Antibodies, Antinuclear; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Chronic Disease; Dermatomyositis; Fluorescent Antibody Technique; Hepatitis; Humans; Hydantoins; Hydralazine; Isoniazid; Latex Fixation Tests; Lupus Erythematosus, Systemic; Methods; Neutrophils; Polyarteritis Nodosa; Scleroderma, Systemic; Sjogren's Syndrome; Thymus Neoplasms | 1969 |
2 other study(ies) available for hydantoins and Sclerosis, Systemic
Article | Year |
---|---|
Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin.
Topics: Acetylation; Adult; Biotransformation; Dapsone; Debrisoquin; Disease Susceptibility; Female; Humans; Hydantoins; Hydroxylation; Isoquinolines; Logistic Models; London; Male; Mephenytoin; Middle Aged; Oxidation-Reduction; Scleroderma, Systemic; Tennessee | 1990 |
[Scleroderma associated with continuous electric muscular activity].
Topics: Adolescent; Electrophysiology; Humans; Hydantoins; Male; Myositis; Scleroderma, Systemic | 1965 |